What does PHARMACIE DU CENTRE do?

PHARMACIE DU CENTRE is a pharmacy in Namur. Private Limited, started on 27 March 2013, 1 establishment.

What is the address of PHARMACIE DU CENTRE?

The registered office of PHARMACIE DU CENTRE is located at Av. du Bourg. Jean Materne(JB) 136, 5100 Namur.

Is PHARMACIE DU CENTRE still active?

Yes. According to the CBE (29 September 2026) PHARMACIE DU CENTRE is active, legal situation “Normale toestand”, started on 27 March 2013.

Is PHARMACIE DU CENTRE registered on Peppol?

Yes, PHARMACIE DU CENTRE is registered on the Peppol network with ID 0208:0524874720.

What is the enterprise number of PHARMACIE DU CENTRE?

The enterprise number of PHARMACIE DU CENTRE is BE0524874720.

When was PHARMACIE DU CENTRE founded?

PHARMACIE DU CENTRE was founded on 27 March 2013.

Who are the directors of PHARMACIE DU CENTRE?

According to the 2025 annual accounts, the directors of PHARMACIE DU CENTRE are: BRISBOIS IMMO SRL.

Is PHARMACIE DU CENTRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 March 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DU CENTRE make in 2025?

PHARMACIE DU CENTRE posted a profit after taxes of € 96,715 in financial year 2025.

What is the revenue of PHARMACIE DU CENTRE?

As a small company, PHARMACIE DU CENTRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 630,650.

How much does an employee at PHARMACIE DU CENTRE earn?

The average wage cost per full-time employee at PHARMACIE DU CENTRE was € 59,400 in 2025: staff costs of € 469,374 for 7.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DU CENTRE have?

According to the 2025 annual accounts, PHARMACIE DU CENTRE has 7.9 full-time equivalents (FTE).

PHARMACIE DU CENTRE (Private Limited) - Namur

Dossier PHARMACIE DU CENTRE, printed on 29 September 2026 from databakkes.be/en/0524874720/pharmacie-du-centre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DU CENTRE from Namur, company number BE0524874720, closed financial year 2025 with a result of € 96,715 after tax. For that financial year PHARMACIE DU CENTRE recorded a gross margin of € 630,650 and equity of € 558,862. Compared with financial year 2024, the result moved from € 129,548 to € 96,715. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Healthy

€ 558,862

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 96,715

▼ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 231,791

▼ 55% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 228,700 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

7.9

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 469,374

€ 59,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 78,249

▼ 6% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 146,485

▼ 73% vs 2024

€ 25,257 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 52,070

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 68,051

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 688,122 Gross margin 2022: € 688,122 First fiscal year in the series	€ 757,446 Gross margin 2023: € 757,446 ▲ 10% vs 2022 (€ 688,122) Favourable step	€ 768,940 Gross margin 2024: € 768,940 ▲ 2% vs 2023 (€ 757,446) Favourable step	€ 630,650 Gross margin 2025: € 630,650 ▼ 18% vs 2024 (€ 768,940) Unfavourable step	▼ 18%
Profit after taxes	€ 147,532 Profit after taxes 2022: € 147,532 First fiscal year in the series	€ 170,565 Profit after taxes 2023: € 170,565 ▲ 16% vs 2022 (€ 147,532) Favourable step	€ 129,548 Profit after taxes 2024: € 129,548 ▼ 24% vs 2023 (€ 170,565) Unfavourable step	€ 96,715 Profit after taxes 2025: € 96,715 ▼ 25% vs 2024 (€ 129,548) Unfavourable step	▼ 25%
Equity	€ 628,733 Equity 2022: € 628,733 First fiscal year in the series	€ 657,598 Equity 2023: € 657,598 ▲ 5% vs 2022 (€ 628,733) Favourable step	€ 690,847 Equity 2024: € 690,847 ▲ 5% vs 2023 (€ 657,598) Favourable step	€ 558,862 Equity 2025: € 558,862 ▼ 19% vs 2024 (€ 690,847) Unfavourable step	▼ 19%
Total debts	€ 691,131 Total debts 2022: € 691,131 First fiscal year in the series	€ 713,423 Total debts 2023: € 713,423 ▲ 3% vs 2022 (€ 691,131) Unfavourable step	€ 770,371 Total debts 2024: € 770,371 ▲ 8% vs 2023 (€ 713,423) Unfavourable step	€ 282,790 Total debts 2025: € 282,790 ▼ 63% vs 2024 (€ 770,371) Favourable step	▼ 63%
Cash	€ 418,345 Cash 2022: € 418,345 First fiscal year in the series	€ 285,870 Cash 2023: € 285,870 ▼ 32% vs 2022 (€ 418,345) Unfavourable step	€ 516,916 Cash 2024: € 516,916 ▲ 81% vs 2023 (€ 285,870) Favourable step	€ 231,791 Cash 2025: € 231,791 ▼ 55% vs 2024 (€ 516,916) Unfavourable step	▼ 55%
Retained profit	€ 616,333 Retained profit 2022: € 616,333 First fiscal year in the series	€ 645,198 Retained profit 2023: € 645,198 ▲ 5% vs 2022 (€ 616,333) Favourable step	€ 678,447 Retained profit 2024: € 678,447 ▲ 5% vs 2023 (€ 645,198) Favourable step	€ 546,462 Retained profit 2025: € 546,462 ▼ 19% vs 2024 (€ 678,447) Unfavourable step	▼ 19%
Dividend	€ 293,370 Dividend 2022: € 293,370 First fiscal year in the series	€ 141,700 Dividend 2023: € 141,700 ▼ 52% vs 2022 (€ 293,370) Unchanged	€ 96,300 Dividend 2024: € 96,300 ▼ 32% vs 2023 (€ 141,700) Unchanged	€ 228,700 Dividend 2025: € 228,700 ▲ 137% vs 2024 (€ 96,300) Unchanged	▲ 137%
Bank debt	€ 154,599 Bank debt 2022: € 154,599 First fiscal year in the series	€ 410,199 Bank debt 2023: € 410,199 ▲ 165% vs 2022 (€ 154,599) Unfavourable step	€ 534,094 Bank debt 2024: € 534,094 ▲ 30% vs 2023 (€ 410,199) Unfavourable step	€ 146,485 Bank debt 2025: € 146,485 ▼ 73% vs 2024 (€ 534,094) Favourable step	▼ 73%
Balance sheet total	€ 1,319,865 Balance sheet total 2022: € 1,319,865 First fiscal year in the series	€ 1,371,021 Balance sheet total 2023: € 1,371,021 ▲ 4% vs 2022 (€ 1,319,865) Unchanged	€ 1,461,218 Balance sheet total 2024: € 1,461,218 ▲ 7% vs 2023 (€ 1,371,021) Unchanged	€ 841,652 Balance sheet total 2025: € 841,652 ▼ 42% vs 2024 (€ 1,461,218) Unchanged	▼ 42%
Employees (FTE)	8.6 Employees (FTE) 2022: 8.6 First fiscal year in the series	8.1 Employees (FTE) 2023: 8.1 ▼ 0.5 vs 2022 (8.6) Unchanged	8.5 Employees (FTE) 2024: 8.5 ▲ 0.4 vs 2023 (8.1) Unchanged	7.9 Employees (FTE) 2025: 7.9 ▼ 0.6 vs 2024 (8.5) Unchanged	▼ 0.6

Key figures of PHARMACIE DU CENTRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DU CENTRE?

What happened at PHARMACIE DU CENTRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 96,715 (▼ 25% vs 2024). Source: NBB ↗
2025 BRISBOIS IMMO SRL became a director. NBB
Mar 27, 2013 New establishment in Namur. KBO
Mar 27, 2013 Start of the company according to the CBE. KBO

In short

From € 147,532 profit in 2022 to € 96,715 profit in 2025.

Paid € 230,417 in corporate taxes since 2022.

Best year ever: 2023, with € 170,565 profit.

On average € 79,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DU CENTRE? We notify you, reason included.

Follow PHARMACIE DU CENTRE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit